Gyre Therapeutics Files 8-K on Financials
Ticker: GYRE · Form: 8-K · Filed: Mar 17, 2025 · CIK: 1124105
| Field | Detail |
|---|---|
| Company | Gyre Therapeutics, Inc. (GYRE) |
| Form Type | 8-K |
| Filed Date | Mar 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
TL;DR
GYRE filed an 8-K for financial results - check for details.
AI Summary
On March 17, 2025, Gyre Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational updates were detailed in the provided text.
Why It Matters
This filing indicates Gyre Therapeutics is providing updates on its financial status and operational results to the SEC, which is important for investors to monitor company performance.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for financial reporting and does not contain any immediately alarming information.
Key Players & Entities
- Gyre Therapeutics, Inc. (company) — Registrant
- March 17, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 12770 High Bluff Drive Suite 150 San Diego, CA 92130 (address) — Principal executive offices
- ( 858 ) 567-7770 (phone_number) — Registrant's telephone number
- CATALYST BIOSCIENCES, INC. (company) — Former company name
- TARGACEPT INC (company) — Former company name
FAQ
What specific financial information is being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but the specific details are not provided in the text.
When was the earliest event reported in this filing?
The earliest event reported is dated March 17, 2025.
What is the principal executive office address for Gyre Therapeutics, Inc.?
The principal executive office is located at 12770 High Bluff Drive Suite 150 San Diego, CA 92130.
Has Gyre Therapeutics, Inc. operated under any former names?
Yes, Gyre Therapeutics, Inc. was formerly known as CATALYST BIOSCIENCES, INC. and TARGACEPT INC.
What is the SIC code for Gyre Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Gyre Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 17, 2025 regarding GYRE THERAPEUTICS, INC. (GYRE).